Extracorporeal Membrane Oxygenation for COVID-19: Case Report of Nine Patients

Covid-19, Coronavirus disease 2019; ARDS, Acute respiratory distress syndrome; ECMO, Extracorporeal Membrane Oxygenation; WHO, World Health Organization; ICUs, Intensive care units. Acute respiratory distress syndrome (ARDS) is a fatal comorbidity of critically ill patients with COVID-19, who often...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Jing, Zhang, Xin, Wang, Na, Ran, Linyu, Wang, Shengyun, Huang, Chiungwei, Gao, Wei, Qian, Chenchen, Guo, Wei, Liu, Zhongmin, Li, Qiang, Wang, Feilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632732/
https://www.ncbi.nlm.nih.gov/pubmed/34869406
http://dx.doi.org/10.3389/fmed.2021.697338
Descripción
Sumario:Covid-19, Coronavirus disease 2019; ARDS, Acute respiratory distress syndrome; ECMO, Extracorporeal Membrane Oxygenation; WHO, World Health Organization; ICUs, Intensive care units. Acute respiratory distress syndrome (ARDS) is a fatal comorbidity of critically ill patients with COVID-19, who often end up on respiratory support. However, the safety and effectiveness of Extracorporeal Membrane Oxygenation (ECMO) in the treatment of COVID-19 remains to be elucidated at present. Here, we report on nine patients who received ECMO due to severe SARS-CoV-2 infection in Wuhan, China. Our initial experiences suggest that carefully selecting patients, as well as management by a well-trained team, are critical to implementing ECMO in patients with COVID-19. More randomized controlled trials with larger sample sizes are needed to evaluate the usefulness of ECMO in patients with COVID-19.

Ejemplares similares